Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T16:41:48.480Z.
Calculation as of: 2026-10-06T16:41:48.480Z.
Quote observation: 2026-10-06T16:40:15.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e78bbdb3a8988fdd9fdd63a4dcf124b38851ed281a9b1f93071349952e7e00d5
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
Market Cap
$44.31M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$43.04M
EV/EBIT Ratio
80.19x
TTM Avg
44.61x
3Y Avg
49.72x
5Y Avg
49.72x
Market Cap
$42.36M
EV/EBIT Ratio
N/A
TTM Avg
7.97x
3Y Avg
11.01x
5Y Avg
11.01x
Market Cap
$47.83M
EV/EBIT Ratio
N/A
TTM Avg
398.45x
3Y Avg
398.45x
5Y Avg
398.45x
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CVRx, Inc. (CVRX) | $44.69M | N/A | N/A | N/A | N/A |
| Rapid Micro Biosystems, Inc. (RPID)vs › | $44.31M | N/A | N/A | N/A | N/A |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $45.42M | N/A | N/A | N/A | N/A |
| DarioHealth Corp. (DRIO)vs › | $45.37M | N/A | 17.26x | 19.56x | 25.78x |
| Nano-X Imaging Ltd. (NNOX)vs › | $43.85M | N/A | N/A | N/A | N/A |
| SANUWAVE Health Inc. (SNWV)vs › | $43.04M | 80.19x | 44.61x | 49.72x | 49.72x |
| BioStem Technologies, Inc. (BSEM)vs › | $42.36M | N/A | 7.97x | 11.01x | 11.01x |
| Precipio, Inc. (PRPO)vs › | $41.92M | N/A | N/A | N/A | N/A |
| Precision Optics Corporation, Inc. (POCI)vs › | $47.83M | N/A | 398.45x | 398.45x | 398.45x |
| Lite Strategy, Inc. (LITS)vs › | $49.00M | N/A | N/A | N/A | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
